Browse studies

Find your next paid study

27,270 recruiting studies available now

Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy (MCPAIN)

The research team will perform a comparative-effectiveness sequential, multiple assignment, randomized trial in painful diabetic neuropathy (PDN) patients for …

Painful Diabetic Neuropathy (PDN)Diabetic Nephropathies

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of MichiganNCT07795593

Phase 3

A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of Sapablursen in Polycythemia Vera

The purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of care (SOC) for Polycythemia Vera (PV) ther…

Polycythemia Vera

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ono Pharmaceutical Co., Ltd.NCT07429266

Phase 1

A Phase I Trial Combining Triapine With Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

This phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or as…

Astrocytoma, IDH-Mutant, Grade 2Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Adult Diffuse Midline Glioma, H3 K27-Mutant+4 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06860594

Phase 2

Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EC-18 in Preventing the Progression of COVID-19 Infection to Severe Pneumonia or ARDS

A trial of EC-18 in patients with mild/moderate pneumonia due to COVID-19

Covid19 Pneumonia

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Enzychem Lifesciences CorporationNCT04569227

Phase 1

A Phase Ia/Ib, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic of UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activity of UBX-303061 in patients with rela…

Relapsed/Refractory B-cell Malignancies

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ubix Therapeutics, Inc.NCT06590961

Phase 1

Phase Ib, Open-label Study of Add on Therapy With CK0804 in Participants With Myelofibrosis, With Suboptimal Response to Ruxolitinib

To assess the safety and tolerability of CK0804 as add-on therapy in participants with myelofibrosis, with suboptimal response to ruxolitinib

Myelofibrosis

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Cellenkos, Inc.NCT05423691

Phase 2

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers (I-MAC)

The goal of this study is to evaluate the efficacy and safety of Ivonescimab in participants with advanced, metastatic salivary gland cancers. The name of the…

Salivary Gland CancerAdvanced Salivary Gland CarcinomaMetastatic Salivary Gland Cancer+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT06805617

Observational

Comparing Optimized Models of Primary And Specialist Services for Palliative Care

Palliative care (PC) seeks to reduce suffering and improve quality of life for patients with serious illnesses and their families. National guidelines recommen…

Seriously Ill Hospitalized Patients

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PennsylvaniaNCT07224594

Phase 3

A Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children With Growth Hormone Deficiency in the First Year of Treatment

A prospective, randomized, open-label single-blinded study of 50 subjects with growth hormone deficiency, ages 5 to 15 years in which 25 subjects will initiate…

Growth DisordersGrowth FailureGrowth Hormone Treatment+1 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Northwell HealthNCT06103513

Observational

Effect of Adjunctive Photobiomodulation on Mechanical Allodynia and Postoperative Pain Following Nonsurgical Root Canal Treatment in Teeth With Symptomatic Apical Periodontitis

This randomized, double-blind controlled clinical trial will evaluate whether adjunctive photobiomodulation improves recovery after nonsurgical root canal trea…

Symptomatic Apical PeriodontitisPostoperative PainMechanical Allodynia

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MinnesotaNCT07886723

Observational

OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)

Pediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital…

Cardiac Arrest (CA)

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT07114510

Phase 2

A Randomized Phase II Trial of ASTX727 With Standard Duration Versus Shorter Duration of Venetoclax in Genomically Heterogenous AML Among Adults Aged 60 or Older and Less Fit for Intensive Therapy: A MyeloMATCH Substudy

This phase II MyeloMATCH treatment trial compares ASTX727 with standard duration versus shorter duration of venetoclax for the treatment of newly diagnosed acu…

Acute Myeloid Leukemia

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07437950